Skip to main content
English

Suche

  1. Home
  2. Suche

Webseiten-Inhalte

CRYM protein suppresses overactive thyroid hormones ... researchers led by Lukas Kenner from the Department of Pathology at MedUni Vienna describes the molecular properties of the CRYM protein, its mode of action in various tissues and its role in obesity and diseases such as diabetes and, in particular, cancer. Thyroid hormones are essential regulators of... https://www.meduniwien.ac.at/web/en/ueber-uns/news/2022/news-im-november-2022/protein-crym-daempft-uebertriebene-schilddruesenhormon-aktivitaet/medicine-science/
CRYM protein suppresses overactive thyroid hormones ... researchers led by Lukas Kenner from the Department of Pathology at MedUni Vienna describes the molecular properties of the CRYM protein, its mode of action in various tissues and its role in obesity and diseases such as diabetes and, in particular, cancer. Thyroid hormones are essential regulators of... https://www.meduniwien.ac.at/web/en/ueber-uns/news/2022/news-im-november-2022/protein-crym-daempft-uebertriebene-schilddruesenhormon-aktivitaet/
Detailsite | MedUni Vienna ... Forschungsinitiative von ALK-abhängigen Krebserkrankungen ERIA bildet das Herzstück eines erfolgreichen Antrags (ALKATRAS) für ein europäisches Trainingsnetzwerk (ETN). Suzanne Turner von der Universität von Cambridge, Lukas Kenner (Ludwig Boltzmann Institut für Krebsforschung (LBI-CR) sowie MedUni Wien) sowie Olaf... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/in-german-eu-grant-fuer-krebsforschungs-trainingsnetzwerk-unter-mitwirkung-der-meduni-wien/
News ...-abhängigen Krebserkrankungen ERIA bildet das Herzstück eines erfolgreichen Antrags (ALKATRAS) für ein europäisches Trainingsnetzwerk (ETN). Suzanne Turner von der Universität von Cambridge, Lukas Kenner (Ludwig Boltzmann Institut für Krebsforschung (LBI-CR) sowie MedUni Wien) sowie Olaf Merkel und Gerda... https://www.meduniwien.ac.at/web/ueber-uns/news/detail/eu-grant-fuer-krebsforschungs-trainingsnetzwerk-unter-mitwirkung-der-meduni-wien/
Detailsite | MedUni Vienna ... led by Lukas Kenner of MedUni Vienna has now identified a gene, AF1q, as being substantially responsible for this and recognized it as a possible starting point for more accurate diagnosis and potential targeted therapeutic approaches. (Vienna, 15-06-2015) A particular human gene variant makes breast cancer cells more aggressive. Not only are these more resistant to chemotherapy but also leave the primary tumour and establish themselves in other parts of the body in the form of metastases. An international group of researchers led by Lukas Kenner of MedUni Vienna and William Tse at James Graham Brown... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/breast-cancer-cells-form-metastases-the-responsible-gene-is-identified/
Detailsite | MedUni Vienna ... Lukas Kenner for the Clinical Institute of Pathology at MedUni Vienna. Scientists believe that in conventional chemotherapy, cancer cells which spread through the body are destroyed, but not the original “cancer stem cells” by which the tumour is produced. As Lukas Kenner, Director of the Institute of... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/cause-of-an-aggressive-form-of-childhood-cancer-identified/
Prostate cancer: Protein identified to reduce tumour growth ... prostate is the second most common cause of cancer death in men. An international study led by Lukas Kenner (MedUni Vienna) and Sabine Lagger (Vetmeduni Vienna) has now identified a protein that could slow tumour growth. The results, which have just been published in the top journal "Molecular Cancer... https://www.meduniwien.ac.at/web/en/ueber-uns/news/2024/default-6e9bbc87ad/prostate-cancer-protein-identified-to-reduce-tumour-growth/
Prostate cancer: Protein identified to reduce tumour growth ... prostate is the second most common cause of cancer death in men. An international study led by Lukas Kenner (MedUni Vienna) and Sabine Lagger (Vetmeduni Vienna) has now identified a protein that could slow tumour growth. The results, which have just been published in the top journal "Molecular Cancer... https://www.meduniwien.ac.at/web/en/ueber-uns/news/2024/default-6e9bbc87ad/prostate-cancer-protein-identified-to-reduce-tumour-growth/medicine-science/
Prostatakrebs: Spezielles Gen weist auf bessere Überlebenschance hin ... der gemeinsamen Arbeit eines Forschungsteams um Monika Oberhuber unter der Leitung von Lukas Kenner vom Institut für Klinische Pathologie der MedUni Wien und des COMET-Forschungszentrums CBmed in Graz konnte anhand einer Datenanalyse nachgewiesen werden, dass ein höheres Vorkommen des Gens PDK4 im... https://www.meduniwien.ac.at/web/ueber-uns/news/detailseite/2020/news-im-april-2020/prostatakrebs-spezielles-gen-weist-auf-bessere-ueberlebenschance-hin/
Prostatakrebs: Spezielles Gen weist auf bessere Überlebenschance hin ... der gemeinsamen Arbeit eines Forschungsteams um Monika Oberhuber unter der Leitung von Lukas Kenner vom Institut für Klinische Pathologie der MedUni Wien und des COMET-Forschungszentrums CBmed in Graz konnte anhand einer Datenanalyse nachgewiesen werden, dass ein höheres Vorkommen des Gens PDK4 im... https://www.meduniwien.ac.at/web/ueber-uns/news/detailseite/2020/news-im-april-2020/prostatakrebs-spezielles-gen-weist-auf-bessere-ueberlebenschance-hin/medizin-wissenschaft/